DEPARTMENT OF HEALTH AND HUMAN SERVICESMay 5th, 2023FiledMay 5th, 2023National Cancer Institute; Development of Anti-CD30 Monoclonal Antibody; for the Development of HeFi–1, Cooperative Research and Development Agreement
National Cancer Institute; Development of Anti-CD30 Monoclonal Antibody; for the Development of HeFi–1, Cooperative Research and Development Agreement